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DVHPurpose: To implement and evaluate a magnetic resonance imaging atlas-based automated segmentation
(MRI-ABAS) procedure for cortical and sub-cortical grey matter areas deﬁnition, suitable for dose-
distribution analyses in brain tumor patients undergoing radiotherapy (RT).
Patients and methods: 3T-MRI scans performed before RT in ten brain tumor patients were used. The MRI-
ABAS procedure consists of grey matter classiﬁcation and atlas-based regions of interest deﬁnition. The
Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm was applied to structures
manually delineated by four experts to generate the standard reference. Performance was assessed com-
paring multiple geometrical metrics (including Dice Similarity Coefﬁcient – DSC). Dosimetric parameters
from dose–volume-histograms were also generated and compared.
Results: Compared with manual delineation, MRI-ABAS showed excellent reproducibility [median
DSCABAS = 1 (95% CI, 0.97–1.0) vs. DSCMANUAL = 0.90 (0.73–0.98)], acceptable accuracy [DSCABAS = 0.81
(0.68–0.94) vs. DSCMANUAL = 0.90 (0.76–0.98)], and an overall 90% reduction in delineation time. Dosimet-
ric parameters obtained using MRI-ABAS were comparable with those obtained by manual contouring.
Conclusions: The speed, reproducibility, and robustness of the process make MRI-ABAS a valuable tool for
investigating radiation dose–volume effects in non-target brain structures providing additional standard-
ized data without additional time-consuming procedures.
 2014 Elsevier Ireland Ltd. Radiotherapy and Oncology 112 (2014) 326–331 This is an open access article
under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Late effects, such as cognitive dysfunction (CD), have an impor-
tant impact on the quality of life [1] of patients bearing brain neo-
plasms. The correlation between brain irradiation and CD is well
recognized. Few data are reported on dose–volume relationships
between CD and speciﬁc brain substructures [2–4] partly due to
the complexity of a reliable delineation of different brain regions
for the absence of clear limits among the anatomo-functional
areas. The manual brain deﬁnition is a time-consuming, prone to
error, operator dependent and poorly reproducible process. A mag-
netic resonance imaging atlas-based automated segmentation
(MRI-ABAS) procedure may overcome the drawbacks inherent to
manual operation, but the automated process of adapting normal
brain atlases may be affected by brain anatomy alterations due
to the presence of pathological and/or iatrogenic deformation. Dif-
ferent approaches to segmenting brain with gross abnormalities inan atlas-based framework have been proposed, although in clinical
practice their use is still limited [5]. In the radiotherapy (RT) con-
text, MRI-ABAS procedures, taking into account tumor deformation
effects, have been suggested and validated by comparing manual
and automated delineation of the brain structures. However, these
procedures were mainly focused on intracranial structures conven-
tionally considered as organs at risk in brain RT treatment plan-
ning, such as brain stem, cerebellum, and optic chiasm [6–8].
The purpose of this work was to validate an MRI-ABAS proce-
dure for cortical and sub-cortical grey matter areas deﬁnition, suit-
able for dose-distribution analyses in studies of RT-related CD. The
key elements of the procedure are a preliminary deﬁnition of MRI-
based grey matter maps and an atlas-based grey matter ROI deﬁni-
tion. Our approach is validated by comparing the segmentation
results with those obtained through four manual experts’ delinea-
tions on a dataset of ten patients undergoing 3D conformal radio-
therapy for primary brain tumors. The MRI-ABAS procedure
performance was assessed by comparing multiple geometrical
metrics, along with the dosimetric evaluations obtained by dose–
volume-histogram (DVHs) calculations.
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Patients database
We considered ten consecutive patients affected by high grade
glioma (who were either biopsied or partially or ‘‘completely’’
resected) treated at our institution. Three-dimensional conformal
plans were generated using a commercial treatment planning sys-
tem (XiO, Elekta CMS). RT was administered using two or more
non-coplanar 6 MV photon beams from a linear accelerator with
a total dose of 60 Gy in 30 daily fractions of 2 Gy. Before RT, all
patients underwent brain MRI (3 Tesla MR scanner Trio, Siemens
Medical Systems, Erlangen, Germany). MRI studies included
three-dimensional, T1-weighted gradient-echo sequences
(MPRAGE, T1 W 1mm3 voxel) before and after i.v. injection of con-
trast medium, diffusion-weighted, FLAIR and TSE-T2 W images in
the axial plane. The MPRAGE sequences with contrast medium
were used to manually contour the structural parenchyma distor-
tion (deformed area, DA). For each patient, the DA was blindly con-
toured by four different operators: an expert neuro-radiologist
(M.Q.) and three radiation oncologists (M.C., M.S. and R.P.). Treat-
ment details and DA information are reported in Supplementary
Table S1.MRI-ABAS procedure
MRI-ABAS aims at obtaining a set of grey matter regions of
interest (ROIs) for each MRI study using a standard atlas of the
brain. Accordingly, from the Talairach atlas [9,10] we preliminarily
grouped selected brain sub-regions, obtaining the following cus-
tomized set of 15 brain ROIs: frontal lobes, parietal lobes, occipital
lobes, temporal lobes, cingulate gyrus, medial temporal lobes, insu-
lar lobes, deep grey matter (i.e. basal ganglia plus thalami) and cer-
ebellum. These ROIs were then superimposed on each patient’s
MRI using a set of functions included in the Statistical Parametric
Mapping software (SPM.8, www.ﬁl.ion.ucl.ac.uk/spm/) as brieﬂy
described below.
For each MRI study, a map of the probabilities for each brain
voxel belonging to grey matter (GM) was obtained. DAs were used
as mask to exclude from the processing the brain voxels with
abnormal signal. GM probability map was then converted into a
binary map. To transfer the 15 ROIs in the MRI-space an elastic
deformation was applied. Finally, the intersection of each ROI in
the MRI-space with the GM map provided the automated ROI-
set. Further details of the MRI-ABAS procedure are reported in
the Supplementary Material Section.Dosimetric analysis
The ROI-sets were converted in DICOM-RT format using a
home-made software (Brain Converter, BRACO) developed in MAT-
LAB (version 7.6.0.324, The Mathworks, Inc., Natick, MA). For each
ROI, BRACO extracts the coordinates of the contours and compiles
the corresponding RT structure-set ﬁle. The MPRAGE sequences
without contrast medium were co-registered with the correspond-
ing planning CT-scan using the automated rigid body co-registra-
tion method based on the mutual information algorithm
embedded in SPM [11]. The RT structure-set ﬁles were transferred
from the MRI-space into the planning CT-space using the resulting
co-registration matrix. Superimposing the dose map from each
patient, the dosimetric evaluation was performed using the Com-
putational Environment for Radiotherapy Research (CERR) soft-
ware [12]. The DVHs were generated for each ROI (automated
and manual) and the mean dose (Dmean), the dose to 95% of volume
(D95), and the dose to 5% of volume (D5) were calculated as repre-
sentative metrics.The execution time for each study was recorded for both the
automated (including DA delineation and computer time) and
manual procedures.Validation procedure
For each study, four sets of manual GM ROIs were generated. To
this end, the brain structures were manually delineated on MRI
images by the four aforementioned operators, using the Talairach
atlas as guidance, and the intersection of each ROI with the GM
map provided the manual ROI-set.
The Simultaneous Truth and Performance Level Estimation
(STAPLE) algorithm [13] was used to generate, from the four man-
ual ROI-sets, a probabilistic estimate of the reference manual ROI-
set (STAPLE-manual), used as ground-truth for the present
validation.
Similarly, using the four DA objects deﬁned by each operator,
four different automated ROI-sets have been obtained for each
study. To assess the inﬂuence of the DA contour variability on
the automated results, a probabilistic estimate of the reference
automated ROI-set (STAPLE-auto) was also obtained.
To quantify inter-operator and between-method differences,
the following eight metrics were used: the relative volume differ-
ences in ROIs’ volumes (DVolume, i.e. volume measurement error)
and the Dice Similarity Coefﬁcient (DSC, i.e. degree of volumetric
overlap) [14] as volumetric measures; the mean absolute surface
distance (MSD) [15] and the mean slice-wise Hausdorff distance
(MSHD) [15] as shape error measures; the distance between the
centres of mass (DCOM, i.e. position error) as distance metrics;
the differences in Dmean, D5 and D95 (DDmean, DD5 and DD95) as
dosimetric measures.
The validation procedure included three evaluations: (a) direct
assessment of inter-operator variability and evaluation of MRI-
ABAS in this framework, (b) assessment of MRI-ABAS reproducibil-
ity with respect to STAPLE-auto, and (c) assessment of MRI-ABAS
accuracy with respect to STAPLE-manual.Inter-operator variability
Pairwise comparisons between each couple of the four opera-
tors (identiﬁed as R1, R2, R3, R4), and between each operator and
STAPLE-auto were performed. This analysis allowed to assess
whether STAPLE-auto differed more from the operators than the
operators did from each other. Inter-operator analysis was per-
formed by the Mann–Whitney test (p < 0.05, two-sided, were con-
sidered statistically signiﬁcant).Reproducibility
The eight metrics were calculated between automated ROIs and
STAPLE-auto (as measure of the robustness of MRI-ABAS in relation
to DA contour variability), and compared to the corresponding
metrics calculated between manual ROIs and STAPLE-manual.
Reproducibility differences between the two methods (MRI-ABAS
vs. manual) were assessed by the Wilcoxon’s signed-rank test for
paired data.Accuracy
The eight metrics were calculated between automated ROIs and
STAPLE-manual. The accuracy of MRI-ABAS was considered as
acceptable, when for each metric, the median value fell within
the 95% reference interval (e.g. non parametric 95% conﬁdence
interval) [16] of the manual method.
All left and right brain structure pairs were combined for both
the geometric and the dosimetric analyses.
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For the entire ROI-set, the mean execution time for the auto-
mated procedure (performed on a hardware platform Intel Core2
Q6600 with 4 GB RAM) compared to manual delineation was 20
vs. 250 min, respectively.
The differences between the automated ROIs and manual ROIs
in the MR-space can be essentially appreciated at the interface
between adjacent lobes, typically not spanning over more than
one sulcus (Fig. 1). Differences in dose–volume distribution
between automated RT and manual RT contours are shown in
Fig. 2 where an example of DVH comparison for three representa-
tive structures of one of the analysed patients is reported.Inter-operator variability
From the pairwise comparisons analysis, it emerged that the
operators signiﬁcantly differed from each other more than from
MRI-ABAS (Supplementary Table S2). Over all structures and all
patients, the mean DSC was 0.89 for MRI-ABAS and 0.87 for the
operators as group (p < 0.001).Reproducibility
Compared to the manual method, MRI-ABAS showed signiﬁ-
cantly higher values of DSC, with corresponding lower DVolume,
MSD, MSHD and DCOM values (p < 0.001 for all the metrics and
regions, Supplementary Table S3). The three dosimetric parameters
showed the same behaviour, in agreement with an expected higher
reproducibility of the automated procedure (Table 1).Accuracy
When comparing MRI-ABAS with STAPLE-manual, all the met-
rics were within the reference interval of the manual method, with
the exception of the DSC of insular, frontal, occipital and temporal
lobes (Supplementary Table S3). The other metrics out of the refer-
ence interval were the MSD of the temporal lobes, and the MSHD of
frontal lobes. However, all these ROIs showed overall a median DSC
above 0.75 and a MSD lower than 1 mm, suggesting an acceptable
degree of accuracy of the automated method compared to manual
delineation. The median values of DDmean, DD5 and DD95 for all
the automated ROIs were within the reference intervals measured
for the manual ROIs (Table 1), thus suggesting a substantial agree-
ment between MRI-ABAS and manual delineation from a dosimet-
ric point of view (Fig. 3).Fig. 1. Automated atlas-based magnetic resonance imaging segmentation (MRI-ABAS) pr
atlas-based and (b) manual delineation grey matter ROIs overlay on axial MRI images; (c)
delineation; differences are highlighted in yellow. DA = deformed area (red), FL = fron
interpretation of the references to color in this ﬁgure legend, the reader is referred to thDiscussion
In the present study we implemented a magnetic resonance
atlas-based automated segmentation procedure for cortical and
sub-cortical grey matter areas deﬁnition. The proposed procedure
showed to be well-suited for CD-related dose distribution analyses
providing additional standardized data without additional time-
consuming procedures.
Indeed, to investigate the correlations between irradiation of
brain sub-sites and speciﬁc side effects, it is essential to identify
and outline critical anatomical regions. Moreover, in order to
gather and relate clinical variables, a standard and reproducible
segmentation methodology should be implemented [1]. In this
framework, brain substructures delineation is particularly chal-
lenging and the employment of automated delineation procedures
could represent a helpful and desirable solution.
In the presence of space occupying lesions and/or deformations,
MRI-ABAS procedures have been proposed by several research
groups, and the application of the MRI-ABAS procedure to the
delineation of conventionally considered OARs in brain RT treat-
ment planning has been investigated [6–8]. Cabezas et al. [5] have
reviewed a series of methodologies, characterized by different
degrees of complexity, none of which reached the ultimate step
of a full dosimetric validation. In addition, commercial ABAS soft-
ware packages have been recently evaluated [7,17,18]. However,
with regard to the cortical and sub-cortical grey matter areas def-
inition, few authors reported on the MRI-ABAS application in the
presence of tumor [19–21], and so far no quantitative analysis of
the resulting dosimetric accuracy in a clinical setting has been
reported.
In this paper we present a robust, reliable and fast MRI-ABAS
procedure based on established neuroimaging procedures [22].
All the elements of our framework were integrated in a pipeline
that generated the RT structure-set ﬁle starting from the CT plan-
ning scan, MRI scan and deformed area contour.
The method’s performance has been assessed estimating geo-
metric and dosimetric parameters in ten brain tumor patients.
After performing the geometric evaluation of MRI-ABAS in the con-
text of inter-operator variability, the automated method has been
compared to an estimated ground truth represented by the manual
delineations performed by four different operators, optimally
merged using STAPLE. From the inter-operator analysis, it emerged
that the operators signiﬁcantly differed from each other more than
fromMRI-ABAS. In a framework of challenging manual delineation,
this evidence suggests the usefulness of an automated method for
the brain structures identiﬁcation.ocedure and a single operator manual delineation for one representative patient: (a)
overlay on the grey matter map of the subtraction between atlas-based and manual
tal lobes (magenta), PL = parietal lobes (green), CG = cingulate gyrus (blue). (For
e web version of this article.)
Fig. 2. Dose distributions and dose–volume histograms (DVHs) relative to the automated atlas-based magnetic resonance imaging segmentation (MRI-ABAS) procedure and a
single operator manual delineation for one representative patient: (a) the automated RT contours and (b) manual delineation RT contours and the relative dose distribution
are overlaid on axial CT images. In (c) the DVHs of cingulate gyrus, frontal and parietal lobes for the automated RT contours (dashed lines) and for the manual delineation
contours (solid lines) are reported. Deformed area (red), frontal lobes (magenta), parietal lobes (green), cingulate gyrus (blue). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
The mean dose (Dmean), the dose to 95% of volume (D95) and the dose to 5% of volume (D5) are referred to the ground truth (STAPLE-manual). The median values and the 95%
reference intervals for the differences in Dmean (DDmean), in D95 (DD95) and in D5 (DD5). All left and right brain structure pairs are combined.
Dmean
(Gy)
DDmean
(Gy)
D95
(Gy)
DD95
(Gy)
D5
(Gy)
DD5
(Gy)
Manual vs.
STAPLE
manual
Auto vs.
STAPLE
manual
Auto vs.
STAPLE
auto
Manual vs.
STAPLE
manual
Auto vs.
STAPLE
manual
Auto vs.
STAPLE
auto
Manual vs.
STAPLE
manual
Auto vs.
STAPLE
manual
Auto vs.
STAPLE
auto
DGM 39.22 0.34
(0.00;
2.07)
0.75
(0.06;
1.49)
0.01
(0.00;
0.19)
16.6 0.36
(0.00; 2.88)
0.44
(0.00; 3.83)
0.02
(0.00;
1.04)
57.59 0.05
(0.00; 1.02)
0.08
(0.01; 0.42)
0.01
(0.00;
0.04)
CBL 16.88 0.15
(0.00;
0.81)
0.16
(0.03;
1.44)
0.00
(0.00;
0.01)
2.95 0.02
(0.02; 0.28)
0.02
(0.00; 0.1)
0.00
(0.00;
0.01)
26.7 0.06
(0.01; 0.96)
0.25
(0.06; 2.73)
0.00
(0.00;
0.04)
CG 36.62 1.71
(0.02;
6.41)
1.78
(0.02;
4.47)
0.01
(0.00;
0.05)
3.71 0.11
(0.00;
13.35)
0.50
(0.02; 2.49)
0.00
(0.00;
0.05)
59.92 0.15
(0.01; 0.63)
0.07
(0.00; 0.47)
0.01
(0.00;
0.06)
FL 28.76 0.53
(0.01;
3.23)
1.22
(0.04;
3.04)
0.01
(0.00;
0.29)
1.19 0.05
(0.00; 3.66)
0.14
(0.00;
16.26)
0.00
(0.00; 0.5)
60.75 0.07
(0.00; 4.97)
0.13
(0.04; 3.49)
0.00
(0.00;
0.06)
INS 27.71 0.36
(0.02;
4.51)
0.66
(0.19;
3.83)
0.01
(0.00;
0.18)
16.82 0.56
(0.00; 8.64)
0.28
(0.02; 9.55)
0.01
(0.00;
0.40)
56.02 0.10
(0.00; 1.38)
0.15
(0.02; 1.72)
0.00
(0.00;
0.22)
MTL 26.5 0.56
(0.00;
3.92)
0.47
(0.03;
3.69)
0.01
(0.00;
0.35)
16.78 0.27
(0.01; 3.05)
0.35
(0.00;
16.28)
0.00
(0.00;
0.08)
45.77 0.36
(0.00; 6.35)
0.98
(0.02;
15.72)
0.01
(0.00;
1.64)
OL 16.93 0.39
(0.01;
2.77)
0.53
(0.01;
2.67)
0.00
(0.00;
0.04)
10.64 0.14
(0.01; 6.15)
0.16
(0.00; 5.74)
0.00
(0.00;
0.06)
25.67 0.30
(0.00; 5.65)
0.22
(0.01; 3.06)
0.01
(0.00;
0.06)
PL 23.89 0.78
(0.02;
5.37)
0.59
(0.01;
2.14)
0.01
(0.00;
0.11)
4.28 0.19
(0.00;
33.96)
0.17
(0.00;
12.91)
0.00
(0.00;
0.20)
56.63 0.55
(0.00;
17.13)
0.26
(0.00;
12.47)
0.01
(0.00;
0.42)
TL 22.95 0.71
(0.02;
6.04)
1.07
(0.12;
5.40)
0.00
(0.00;
0.05)
1.61 0.14
(0.01; 1.77)
0.12
(0.00; 2.08)
0.00
(0.00;
0.09)
48.24 0.44
(0.05; 4.60)
0.79
(0.02; 6.16)
0.00
(0.00;
0.17)
Overall 0.52
(0.01;
4.21)
0.65
(0.02;
3.83)
0.01
(0.00;
0.14)
0.13
(0.00; 7.71)
0.16
(0.00;
12.90)
0.00
(0.00;
0.23)
0.17
(0.00; 6.73)
0.23
(0.01; 9.10)
0.01
(0.00;
0.24)
Abbreviations: Frontal lobes (FL), parietal lobes (PL), occipital lobes (OL), temporal lobes (TL), cingulate gyrus (CG), medial temporal lobes (MTL), insular lobes (INS), deep grey
matter (DGM) and cerebellum (CBL).
M. Conson et al. / Radiotherapy and Oncology 112 (2014) 326–331 329An expected result is represented by the higher reproducibility
of the automated method when compared with the manual delin-
eation procedure in terms of spatial overlap, surface error and posi-tion error. Due to the relative insensitivity of MRI-ABAS to the
variations of the deformed area, the high degree of reproducibility
suggests that the proposed method is robust. The signiﬁcantly
Fig. 3. Correlation plots relative to the dosimetric parameters from (a) the
automated RT contours and from (b) the manual RT contours from all individual
operators with respect to STAPLE-manual. The mean dose (Dmean, blue diamond),
the dose to 5% of volume (D5, red circle), and the dose to 95% of volume (D95, green
triangle) are reported. The correlation plots illustrate the overall agreement with
respect to the ground truth (STAPLE-manual) for both MRI-ABAS and manual
delineation. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
330 Automated delineation of brain regions in RT patientshigher reproducibility of MRI-ABAS resulted also in a higher repro-
ducibility in terms of dosimetric parameters.
As to accuracy, the spatial overlap was overall satisfactory: the
median DSC being 0.81 (95% CI, 0.68–0.94). The values of spatial
overlap are comparable to those reported by other authors for sim-
ilar, although not identical, brain structures. Isambert et al. [7] con-
cluded that automated segmentation was well suited for organs
like cerebellum, with DSC values around 0.8–0.9, while smaller
structures showed lower values (0.4–0.5). In our case also, the
highest DSC values were observed for larger structures like the cer-
ebellum and frontal lobes (0.94 and 0.87, respectively), while the
lowest DSC values were obtained for medial temporal lobes
(0.78), for insular lobes and the cingulated gyrus (0.75). Of course,
other factors, such as the shape of the structures and their position
within the brain, can also have an effect in this respect [8].
Of note, the DSC median values for all the structures that fell
outside the reference intervals were nonetheless above 0.7. This
threshold is generally considered as indicative of an acceptable
overlap in the validation studies of biomedical image processing
techniques [23,24], although further evidence will be needed inthe future to support this cut-off value in the context of RT-related
CD studies. Interestingly, for frontal and temporal lobes the MRI-
ABAS showed an accuracy below the reference intervals deﬁned
by the manual method despite median DSC values above 0.80 in
both cases. This is due to the high reproducibility of the manual
delineation of these structures which have large sizes and rela-
tively clear anatomical boundaries. The shape and position errors
for MRI-ABAS were comparable with those derived from the man-
ual delineation.
Of note, in deﬁning the acceptability criteria for the accuracy of
the automated method, our aim was to compare the accuracy of
the latter to an estimate of the range of possible segmentations
obtained manually (deﬁned for each structure by a reference inter-
val), rather than to demonstrate that the automated method was at
least as accurate as the manual one (which had an obvious advan-
tage due to the use of STAPLE-manual as ground truth).
Considering the impact of the automated procedure on dosi-
metric endpoints, the MRI-ABAS procedure provides results com-
parable to those obtained by manual delineation: the
distributions of the median DDmean, DD5 and DD95 for the auto-
mated contours were similar to the corresponding dosimetric
parameters obtained by the manual contours (Fig. 3). Although
the dosimetric accuracy measures of MRI-ABAS were always
within the reference intervals, and despite the fact that the median
values never exceeded 1 Gy, it must be pointed out that for some
structures (medial temporal and parietal lobes) the differences
with the ground truth could exceed 10 Gy. However, for the parie-
tal lobe the DD95 reference interval exceeded 10 Gy also with the
manual method. This is likely due to the difﬁculty for the manual
operator to recognize boundaries that, at least in part for the pari-
etal lobe, are barely discernible. On the other hand, for the medial
temporal lobe, the above mentioned limitations, associated to the
relatively small size of the structure, may in some cases result in
larger errors requiring the manual editing of this structure.
In general, it should be pointed out that the results of the pres-
ent validation cannot be extrapolated to other brain structure sub-
divisions, even if of similar shape and size. Similarly, our analyses
were performed in a 3D-conformal RT setting and the dosimetric
results may be different when different radiation techniques are
used.
In conclusion, the proposed framework for automated delinea-
tion of brain regions in a radiotherapy context was found to be fea-
sible and efﬁcient. The proposed framework shows substantial
efﬁciency with at least 90% reduction in delineation time while
maintaining comparable accuracy and improving reproducibility
from both a geometric and dosimetric point of view. The execution
time may be further reduced using higher performance machines
when large samples have to be handled. Our pipeline has been con-
ceived to be integrated in the clinical radiotherapy process that
leads to the construction of treatment planning. All this makes
MRI-ABAS a valuable tool for investigating radiation dose–volume
effects in non-target brain structures.Conﬂict of interest
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